Vitamins help “fill in the gaps” of a diet by providing us with nutrients we may not be getting enough of, but can they actually lower our risk for common diseases like cancer and heart disease?

Treatment for follicular lymphoma — the most common type of non-Hodgkin lymphoma — often comes with serious side effects. New research may change that for many patients.

While leukemia treatments can be uncomfortable, they also save lives. Still, reducing the discomfort of these treatments remains important, especially for the youngest patients.

Triple-negative breast cancer is a fast-growing form of the disease that tends to return (recur). But a fresh therapeutic approach was found to be capable of eliminating the disease altogether.

For years, postmenopausal breast cancer survivors have been treated with medications that block estrogen production to reduce the risk of cancer returning. One medication may also prevent the disease from developing at all.

A medication that treats a type of leukemia targets a protein that’s involved in the spread of breast cancer. Combining this medication with a standard breast cancer therapy helped some patients live longer.

Aromatase inhibitors (AI) are medications that block production of estrogen, the hormone that feeds most breast cancers.

Breast cancer in older women behaves differently than it does in younger women. Breast cancer is less likely to return in older women. So older women can be treated differently, too, a new study suggests.

What age should breast cancer screening start? How often should it be performed? How many women have to be screened to prevent one breast cancer death? Breast cancer screening is controversial.

Once cancer spreads, controlling it becomes a much more complex challenge. Researchers looked at the survival benefits of treatment alternatives for advanced breast cancer.